Opioid Epidemic Policies
Precious Dixon
Walden University
Population and Advocacy for Improving Health
Dr. Mooring
12/1/2021
The opioid epidemic was declared a public health emergency by the U.S Department of Health and Human Services in 2017 (HHS). Trump’s Administration established a campaign for fighting the opioid crisis, which involved various national departments. The drive took a multiplex approach and included multimedia awareness campaigns, stimulating stricter policies making it harder for criminals to get fentanyl precursors, working with pharmaceutical companies to investigate addiction therapies, and developing anti-addiction vaccines and other measures (DPBH). However, the number of deaths from opioid overdose continued to rise.
Biden Administration took a slightly different approach. Their plan focuses on providing effective prevention treatment and recovery services available to all addicts with the help of a $125 billion federal investment. Biden Office claims that pharmaceutical companies need to be held accountable for contributing to the initiation of the opioid crisis. Arguably, instead of just pouring budget money into various government agencies and departments, there should be an intense focus on giving the medical practitioners the resources for research programs, thus providing practical evidence for implementation in real life. According to chapter 2 of the book by Jeri Milstead and Nancy Short, “By seeking and obtaining a grant from a national organization, nurse leaders can initiate new practices in a health organization” (Milstead & Short, 2019, p.18). Consequently, initiating new practices in health organizations could bring new ways for fighting such multiplex problems as the opioid crisis.
Increasing funding of care coordination programs could contribute to the overall quality of health services. According to the article by Lamb et al., “Expanding funding streams for measure development and testing is essential to improve the state of performance measurement for care coordination” (2015, p.527). Consequently, additional funding of the programs focusing on improving healthcare quality could have an indirect effect on helping battle the opioid crisis.
Although setting a clear national agenda is vital for attacking complex and multi-leveled issues. Still, the extent of the problems like the opioid crisis arguably requires a plan that will maintain a constant course and only require periodic adjustments by the everchanging administration policies. Article by Soelberg et al., discusses the importance of cooperation between federal and state governments in approaches such complex situations. The article suggests that government interventions aimed at more appropriate opioid prescribing, the studies investigating the effect of these interventions should also consider the impact on people suffering from chronic pain (Soelberg et al., 2017, p.1680). Thus, the policymakers should aim to collaborate with agencies and medical practitioners to find the most effective approach.
References
Assistant Secretary of Public Affairs (ASPA). What is the U.S. opioid epidemic? Retrieved
December 1, 2021, from https://www.hhs.gov/opioids/about-the-epidemic/index
.html.
Department of Health and Human Services Nevada Division of Public and Behavioral Health (DPBH). (2017). Background on PH Emergency Declaration Retrieved December 1, 2021, from https://dpbh.nv.gov/uploadedFiles/dpbhnvgov/content/Resources/opioids/Background%20on%20PH%20Emergency%20Declaration.pdf.
Lamb, G., Newhouse, R., Beverly, C., Toney, D. A., Cropley, S., Weaver, C. A., … & Peterson, C. (2015). Policy agenda for nurse-led care coordination. Nursing Outlook, 63(4), 521-530. doi: 10.1016/j.outlook.2015.06.003.
Milstead, J. A., & Short, N. M. (2019). Health policy and politics: A nurse’s guide (6th ed.). Burlington, MA: Jones & Bartlett Learning.
Soelberg, C. D., Brown, R. E., Du Vivier, D., Meyer, J. E., & Ramachandran, B. K. (2017). The US opioid crisis: current federal and state legal issues. Anesthesia & Analgesia, 125(5), 1675-1681. doi: 10.1213/ANE.0000000000002403.